NVS expects the FDA to delay its Gilenia (FTY720) decision past the PDUFA date in June because there are only a few days between the advisory panel on 6/10/10 and the PDUFA date. (Source: Today’s NVS CC)
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”